2/23
07:22 am
glue
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/23
07:00 am
glue
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
2/6
10:46 am
glue
Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) institutional investors lost 12% last week but have benefitted from longer-term gains [Yahoo! Finance]
Low
Report
Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) institutional investors lost 12% last week but have benefitted from longer-term gains [Yahoo! Finance]
2/6
06:31 am
glue
Monte Rosa Therapeutics (NASDAQ:GLUE) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Monte Rosa Therapeutics (NASDAQ:GLUE) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
1/14
07:06 am
glue
Monte Rosa Therapeutics (NASDAQ:GLUE) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Monte Rosa Therapeutics (NASDAQ:GLUE) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
1/10
07:02 pm
glue
Assessing Monte Rosa Therapeutics (GLUE) Valuation After Strong MRT-8102 Phase 1 Data And Share Price Momentum [Yahoo! Finance]
Medium
Report
Assessing Monte Rosa Therapeutics (GLUE) Valuation After Strong MRT-8102 Phase 1 Data And Share Price Momentum [Yahoo! Finance]
1/9
02:22 am
glue
Monte Rosa Therapeutics announces pricing of $300M stock offering [Seeking Alpha]
Medium
Report
Monte Rosa Therapeutics announces pricing of $300M stock offering [Seeking Alpha]
1/8
10:49 pm
glue
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
Medium
Report
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
2/23
05:42 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Janku Filip
Low
Report
Form 144 Monte Rosa Therapeutics, Filed by: Janku Filip
2/17
04:15 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
2/17
04:12 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BAKER BROS. ADVISORS LP
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BAKER BROS. ADVISORS LP
2/11
04:37 pm
glue
Form S-3ASR Monte Rosa Therapeutics,
Low
Report
Form S-3ASR Monte Rosa Therapeutics,
2/10
04:02 pm
glue
Form 8-K Monte Rosa Therapeutics, For: Feb 09
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: Feb 09
1/21
11:59 am
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
1/9
04:32 pm
glue
Form 8-K Monte Rosa Therapeutics, For: Jan 08
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: Jan 08
1/9
04:31 pm
glue
Form 424B5 Monte Rosa Therapeutics,
Medium
Report
Form 424B5 Monte Rosa Therapeutics,
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register